Chronic stable angina treatment: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Maheep Sangha (talk | contribs)
nocaptcha
7,826 edits
No edit summary
Maheep Sangha (talk | contribs)
nocaptcha
7,826 edits
 
(15 intermediate revisions by the same user not shown)
Line 6: Line 6:


==Overview==
==Overview==
Treatment of chronic stable angina aims at minimizing symptoms, reducing recurrent [[ischemia]], improving the quality of life and improving [[Chronic stable angina prognosis|prognosis]] by preventing [[MI]] and death. Treatment options include [[Chronic stable angina secondary prevention|lifestyle modification]], [[Chronic stable angina pharmacotherapy overview|pharmacotherapy]] and [[Chronic stable angina revascularization|revascularization]] that help in slowing the disease progression, preserving the endothelial function and preventing [[thrombosis]].
Treatment of chronic stable angina aims at minimizing symptoms, reducing recurrent [[ischemia]], improving the quality of life and improving [[Chronic stable angina prognosis|prognosis]] by preventing [[MI]] and death. Treatment options include [[Chronic stable angina secondary prevention|lifestyle modification]], [[Chronic stable angina medical therapy|pharmacotherapy]] and [[Chronic stable angina revascularization|revascularization]] that help in slowing the disease progression, preserving the endothelial function and preventing [[thrombosis]].


Patients with [[CAD|single-vessel CAD]] may be started on initial [[Chronic stable angina pharmacotherapy overview|pharmacologic therapy]] and if non-responsive or symptomatic despite on therapy, [[Chronic stable angina revascularization percutaneous coronary intervention(PCI)|PCI]] may be a preferred alternative.
Patients with [[CAD|single-vessel CAD]] may be started on initial [[Chronic stable angina medical therapy|pharmacologic therapy]] and if non-responsive or symptomatic despite on therapy, [[Chronic stable angina revascularization percutaneous coronary intervention|PCI]] may be a preferred alternative.


Patients with [[CAD|double-vessel CAD]] and with [[EF|normal LV function]] may be started on initial [[Chronic stable angina pharmacotherapy overview|medical management]] and in non-responders, [[Chronic stable angina revascularization percutaneous coronary intervention(PCI)|PCI]] may be considered. However, the decision of [[Chronic stable angina revascularization percutaneous coronary intervention(PCI)|PCI]] versus [[Chronic stable angina revascularization coronary artery bypass grafting(CABG)|CABG]] depends on the coronary anatomy, [[EF|LV function]] and the need for complete revascularization.
Patients with [[CAD|double-vessel CAD]] and with [[EF|normal LV function]] may be started on initial [[Chronic stable angina medical therapy|medical management]] and in non-responders, [[Chronic stable angina revascularization percutaneous coronary intervention|PCI]] may be considered. However, the decision of [[Chronic stable angina revascularization percutaneous coronary intervention|PCI]] versus [[Chronic stable angina revascularization coronary artery bypass grafting|CABG]] depends on the coronary anatomy, [[EF|LV function]] and the need for complete revascularization.


Patients with [[CAD|triple-vessel CAD]] or [[left main]] [[CAD|disease]] or reduced [[EF|left ventricular function]], [[Chronic stable angina revascularization coronary artery bypass grafting(CABG)|CABG]] is the mainstay of management. However, in cases of mild symptoms or preserved [[EF|LVEF]] in patients with triple-vessel disease, initial [[Chronic stable angina pharmacotherapy overview|pharmacologic therapy]] or [[Chronic stable angina revascularization percutaneous coronary intervention(PCI)|PCI]] may be tried.
Patients with [[CAD|triple-vessel CAD]] or [[left main]] [[CAD|disease]] or reduced [[EF|left ventricular function]], [[Chronic stable angina revascularization coronary artery bypass grafting|CABG]] is the mainstay of management. However, in cases of mild symptoms or preserved [[EF|LVEF]] in patients with triple-vessel disease, initial [[Chronic stable angina medical therapy|pharmacologic therapy]] or [[Chronic stable angina revascularization percutaneous coronary intervention|PCI]] may be tried.


==Precipitating factors==
==Treatment==
===Precipitating Factors===
*While chronic stable angina may be due to underlying [[atherosclerosis]], other factors may either precipitate or exacerbate angina.  
*While chronic stable angina may be due to underlying [[atherosclerosis]], other factors may either precipitate or exacerbate angina.  


Line 25: Line 26:
:*[[valvular heart disease|Concomitant valvular heart disease]].
:*[[valvular heart disease|Concomitant valvular heart disease]].


==Risk factor modification==
===Risk Factor Modification===
*Initiation of intensive modification of risk factors is an urgent and essential part of the main therapy in chronic stable angina.
*Initiation of intensive modification of risk factors is an urgent and essential part of the main therapy in chronic stable angina.


*Initiate risk factor modification, promote regular physical exercise (all patients should be encouraged to obtain 30 to 60 minutes/day of regular aerobic activity), low fat diet, and lifestyle modification.  
*Initiate risk factor modification, promote regular physical exercise (all patients should be encouraged to obtain 30 to 60 minutes/day of regular aerobic activity), low fat diet, and lifestyle modification.  


*You can read in greater detail about each of the risk factor modification topics below.
*You can read in greater detail about each of the risk factor modification topics below:
[[Chronic stable angina treatment smoking cessation|Smoking Cessation]] | [[Chronic stable angina treatment weight management|Weight Management]] | [[Chronic stable angina treatment physical activity|Physical Activity]] | [[Chronic stable angina treatment lipid management|Lipid Management]] | [[Chronic stable angina treatment blood pressure control|BP Control]] | [[Chronic stable angina treatment diabetes control|Diabetes Control]] | [[Chronic stable angina treatment ACC/AHA guidelines for cardiovascular risk factor reduction|ACC/AHA Guidelines for Cardiovascular Risk Factor Reduction]]


==The treatment essentials==  
:'''[[Chronic stable angina treatment smoking cessation|Smoking Cessation]] | [[Chronic stable angina treatment weight management|Weight Management]] | [[Chronic stable angina treatment physical activity|Physical Activity]] | [[Chronic stable angina treatment lipid management|Lipid Management]] | [[Chronic stable angina treatment blood pressure control|BP Control]] | [[Chronic stable angina treatment diabetes control|Diabetes Control]] | [[Chronic stable angina treatment ACC/AHA guidelines for cardiovascular risk factor reduction|ACC/AHA Guidelines for Cardiovascular Risk Factor Reduction]]'''
Alphabet of chronic stable angina management: elements listed below are the most important components of stable angina management.
 
===The Treatment Essentials===
Alphabet of chronic stable angina management: Elements listed below are the most important components of stable angina management.
*'''A:''' [[Aspirin]] use  
*'''A:''' [[Aspirin]] use  
*'''A:''' Anti anginal therapy
*'''A:''' Anti anginal therapy
Line 46: Line 48:
*'''E:''' Education
*'''E:''' Education


==Pharmacotherapy==
===Pharmacotherapy===
*The role of pharmacotherapy in the management of chronic stable angina is to reduce the severity and frequency of symptoms and to provide a bettered overall prognosis.  
*The role of pharmacotherapy in the management of chronic stable angina is to reduce the severity and frequency of symptoms and to provide a bettered overall prognosis.  


Line 53: Line 55:
*Drugs that improve quality of life and are associated with better prognosis include: [[Chronic stable angina treatment aspirin|low dose aspirin]], [[Chronic stable angina treatment angiotensin converting enzyme inhibitors (ACEI) and renin angiotensin aldosterone system blockers (RAAS blockers)|ACEIs]], [[Chronic stable angina beta blocker therapy|beta-blockers]].
*Drugs that improve quality of life and are associated with better prognosis include: [[Chronic stable angina treatment aspirin|low dose aspirin]], [[Chronic stable angina treatment angiotensin converting enzyme inhibitors (ACEI) and renin angiotensin aldosterone system blockers (RAAS blockers)|ACEIs]], [[Chronic stable angina beta blocker therapy|beta-blockers]].


*You can read in greater detail about each of the pharmacotherapies for chronic stable angina below by clicking on the link for that topic
*You can read in greater detail about each of the pharmacotherapies for chronic stable angina below by clicking on the link for that topic:
:*[[Chronic stable angina pharmacotherapy overview|Overview]]
:*'''[[Chronic stable angina medical therapy|Overview]]'''


:*Antiplatelet agents: [[Chronic stable angina treatment aspirin|Aspirin]] | [[Chronic stable angina treatment dipyridamole|Dipyridamole]] | [[Chronic stable angina treatment clopidogrel|Clopidogrel]]
:*Antiplatelet agents: '''[[Chronic stable angina treatment aspirin|Aspirin]] | [[Chronic stable angina treatment dipyridamole|Dipyridamole]] | [[Chronic stable angina treatment clopidogrel|Clopidogrel]]'''


:*Antianginal agents: [[Chronic stable angina nitrate therapy|Nitrates]] | [[Chronic stable angina beta blocker therapy|Beta Blockers]] | [[Chronic stable angina treatment calcium channel blockers|Calcium Channel Blockers]] | [[Chronic stable angina treatment potassium channel openers|Potassium channel openers]] | [[Chronic stable angina newer antianginal agents|Newer Anti-anginal Agents]]
:*Antianginal agents: '''[[Chronic stable angina nitrate therapy|Nitrates]] | [[Chronic stable angina beta blocker therapy|Beta Blockers]] | [[Chronic stable angina treatment calcium channel blockers|Calcium Channel Blockers]] | [[Chronic stable angina treatment potassium channel openers|Potassium Channel Openers]] | [[Chronic stable angina newer antianginal agents|Newer Anti-anginal Agents]]'''


:*[[Chronic stable angina treatment angiotensin converting enzyme inhibitors (ACEI) and renin angiotensin aldosterone system blockers (RAAS blockers)|ACEI/RAAS blockers]]
:*'''[[Chronic stable angina treatment angiotensin converting enzyme inhibitors (ACEI) and renin angiotensin aldosterone system blockers (RAAS blockers)|ACEI/RAAS Blockers]]'''


:*[[Chronic stable angina treatment anti-lipid agents|Anti-lipid agents]]
:*'''[[Chronic stable angina treatment anti-lipid agents|Anti-lipid Agents]]'''


:*[[Chronic stable angina guidelines for pharmacotherapy to improve prognosis and reduce symptoms|Guidelines for pharmacotherapy to improve prognosis and reduce symptoms]]
:*'''[[Chronic stable angina guidelines for pharmacotherapy to improve prognosis and reduce symptoms|Guidelines for Pharmacotherapy to Improve Prognosis and Reduce Symptoms]]'''


==Revascularization==
===Revascularization===
*[[Revascularization]] is only used for select patients specially those who have uncontrolled symptoms with optimal medical therapy.
*[[Revascularization]] is only used for select patients specially those who have uncontrolled symptoms with optimal medical therapy.


Line 76: Line 78:


*You can read in greater detail about specific revascularization approaches for the treatment of chronic stable angina by clicking on the link below for that topic.
*You can read in greater detail about specific revascularization approaches for the treatment of chronic stable angina by clicking on the link below for that topic.
[[Chronic stable angina revascularization percutaneous coronary intervention(PCI)|PCI]] | [[Chronic stable angina revascularization coronary artery bypass grafting(CABG)|CABG]] | [[Chronic stable angina percutaneous coronary intervention versus coronary artery bypass grafting|PCI vs CABG]] | [[Chronic stable angina ACC/AHA guidelines for revascularization|ACC/AHA Guidelines for Revascularization]]
:'''[[Chronic stable angina revascularization percutaneous coronary intervention|PCI]] | [[Chronic stable angina revascularization coronary artery bypass grafting|CABG]] | [[Chronic stable angina percutaneous coronary intervention versus coronary artery bypass grafting|PCI vs CABG]] | [[Chronic stable angina ACC/AHA guidelines for revascularization|ACC/AHA Guidelines for Revascularization]]'''
 
===Alternative Therapies for Refractory Angina===
You can read in greater detail about each of the alternative therapies for refractory angina below by clicking on the link for that topic:


==Alternative therapies for refractory angina==
*'''[[Chronic stable angina transmyocardial revascularization(TMR)|Transmyocardial Revascularization]]'''
You can read in greater detail about each of the alternative therapies for refractory angina below by clicking on the link for that topic.
*'''[[Chronic stable angina spinal cord stimulation(SCS)|Spinal Cord Stimulation]]'''
[[Chronic stable angina transmyocardial revascularization(TMR)|Transmyocardial Revascularization]] | [[Chronic stable angina spinal cord stimulation(SCS)|Spinal Cord Stimulation]] | [[Chronic stable angina enhanced external counter pulsation(EECP)|Enhanced External Counter Pulsation (EECP)]] | [[Chronic stable angina ACC/AHA guidelines for alternative therapies in patients with refractory angina|ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina]]
*'''[[Chronic stable angina enhanced external counter pulsation(EECP)|Enhanced External Counter Pulsation (EECP)]]'''
*'''[[Chronic stable angina ACC/AHA guidelines for alternative therapies in patients with refractory angina|ACC/AHA Guidelines for Alternative Therapies in Patients with Refractory Angina]]'''


==References==
==References==
Line 87: Line 93:
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Ischemic heart diseases]]
[[Category:Ischemic heart diseases]]
[[Category:Disease]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Intensive care medicine]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date cardiology]]
[[Category:Up-To-Date cardiology]]

Latest revision as of 18:23, 6 February 2013


Chronic stable angina Microchapters

Acute Coronary Syndrome Main Page

Home

Patient Information

Overview

Historical Perspective

Classification

Classic
Chronic Stable Angina
Atypical
Walk through Angina
Mixed Angina
Nocturnal Angina
Postprandial Angina
Cardiac Syndrome X
Vasospastic Angina

Differentiating Chronic Stable Angina from Acute Coronary Syndromes

Pathophysiology

Epidemiology and Demographics

Risk Stratification

Pretest Probability of CAD in a Patient with Angina

Prognosis

Diagnosis

History and Symptoms

Physical Examination

Test Selection Guideline for the Individual Basis

Laboratory Findings

Electrocardiogram

Exercise ECG

Chest X Ray

Myocardial Perfusion Scintigraphy with Pharmacologic Stress

Myocardial Perfusion Scintigraphy with Thallium

Echocardiography

Exercise Echocardiography

Computed coronary tomography angiography(CCTA)

Positron Emission Tomography

Ambulatory ST Segment Monitoring

Electron Beam Tomography

Cardiac Magnetic Resonance Imaging

Coronary Angiography

Treatment

Medical Therapy

Revascularization

PCI
CABG
Hybrid Coronary Revascularization

Alternative Therapies for Refractory Angina

Transmyocardial Revascularization (TMR)
Spinal Cord Stimulation (SCS)
Enhanced External Counter Pulsation (EECP)
ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina

Discharge Care

Patient Follow-Up
Rehabilitation

Secondary Prevention

Guidelines for Asymptomatic Patients

Noninvasive Testing in Asymptomatic Patients
Risk Stratification by Coronary Angiography
Pharmacotherapy to Prevent MI and Death in Asymptomatic Patients

Landmark Trials

Case Studies

Case #1

Chronic stable angina treatment On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic stable angina treatment

CDC onChronic stable angina treatment

Chronic stable angina treatment in the news

Blogs on Chronic stable angina treatment

to Hospitals Treating Chronic stable angina treatment

Risk calculators and risk factors for Chronic stable angina treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; John Fani Srour, M.D.; Jinhui Wu, M.D.; Lakshmi Gopalakrishnan. M.B.B.S.

Overview

Treatment of chronic stable angina aims at minimizing symptoms, reducing recurrent ischemia, improving the quality of life and improving prognosis by preventing MI and death. Treatment options include lifestyle modification, pharmacotherapy and revascularization that help in slowing the disease progression, preserving the endothelial function and preventing thrombosis.

Patients with single-vessel CAD may be started on initial pharmacologic therapy and if non-responsive or symptomatic despite on therapy, PCI may be a preferred alternative.

Patients with double-vessel CAD and with normal LV function may be started on initial medical management and in non-responders, PCI may be considered. However, the decision of PCI versus CABG depends on the coronary anatomy, LV function and the need for complete revascularization.

Patients with triple-vessel CAD or left main disease or reduced left ventricular function, CABG is the mainstay of management. However, in cases of mild symptoms or preserved LVEF in patients with triple-vessel disease, initial pharmacologic therapy or PCI may be tried.

Treatment

Precipitating Factors

  • While chronic stable angina may be due to underlying atherosclerosis, other factors may either precipitate or exacerbate angina.
  • Identification and management of these conditions may reduce the frequency and intensity of anginal episodes. These conditions include:

Risk Factor Modification

  • Initiation of intensive modification of risk factors is an urgent and essential part of the main therapy in chronic stable angina.
  • Initiate risk factor modification, promote regular physical exercise (all patients should be encouraged to obtain 30 to 60 minutes/day of regular aerobic activity), low fat diet, and lifestyle modification.
  • You can read in greater detail about each of the risk factor modification topics below:
Smoking Cessation | Weight Management | Physical Activity | Lipid Management | BP Control | Diabetes Control | ACC/AHA Guidelines for Cardiovascular Risk Factor Reduction

The Treatment Essentials

Alphabet of chronic stable angina management: Elements listed below are the most important components of stable angina management.

Pharmacotherapy

  • The role of pharmacotherapy in the management of chronic stable angina is to reduce the severity and frequency of symptoms and to provide a bettered overall prognosis.
  • You can read in greater detail about each of the pharmacotherapies for chronic stable angina below by clicking on the link for that topic:

Revascularization

  • Revascularization is only used for select patients specially those who have uncontrolled symptoms with optimal medical therapy.
  • In general, PCI is reserved for single or some cases of two vessel disease, and
  • CABG is reserved for patients with two or three vessel disease or left main disease.
  • With the availability of drug-eluting stents, PCI is increasingly being performed for many lesions including more complex ones.
  • You can read in greater detail about specific revascularization approaches for the treatment of chronic stable angina by clicking on the link below for that topic.
PCI | CABG | PCI vs CABG | ACC/AHA Guidelines for Revascularization

Alternative Therapies for Refractory Angina

You can read in greater detail about each of the alternative therapies for refractory angina below by clicking on the link for that topic:

References

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Chronic_stable_angina_treatment&oldid=843233"